vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and STAG Industrial, Inc. (STAG). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $224.2M, roughly 1.1× STAG Industrial, Inc.). STAG Industrial, Inc. runs the higher net margin — 27.6% vs -35.0%, a 62.7% gap on every dollar of revenue. On growth, STAG Industrial, Inc. posted the faster year-over-year revenue change (9.1% vs -23.6%). Over the past eight quarters, STAG Industrial, Inc.'s revenue compounded faster (8.7% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Stag Arms is a firearms manufacturer founded in May 2003 and located in Cheyenne, Wyoming. Stag Arms is a manufacturer of the AR-15 type rifle, marketed as Stag-15 rifles. Stag advertises that all their weapons and accessories are made in the United States. They are best known for their left-handed AR-15 rifles, which use a mirror imaged upper receiver and have the ejection port reversed for left-handed shooters and the safety selector control on the right side of the lower receiver.
CCRN vs STAG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $236.8M | $224.2M |
| Net Profit | $-82.9M | $62.0M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | — |
| Net Margin | -35.0% | 27.6% |
| Revenue YoY | -23.6% | 9.1% |
| Net Profit YoY | -2109.7% | — |
| EPS (diluted) | $-2.56 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $224.2M | ||
| Q4 25 | $236.8M | $220.9M | ||
| Q3 25 | $250.1M | $211.1M | ||
| Q2 25 | $274.1M | $207.6M | ||
| Q1 25 | $293.4M | $205.6M | ||
| Q4 24 | $309.9M | $199.3M | ||
| Q3 24 | $315.1M | $190.7M | ||
| Q2 24 | $339.8M | $189.8M |
| Q1 26 | — | $62.0M | ||
| Q4 25 | $-82.9M | $83.5M | ||
| Q3 25 | $-4.8M | $48.6M | ||
| Q2 25 | $-6.7M | $50.0M | ||
| Q1 25 | $-490.0K | $91.4M | ||
| Q4 24 | $-3.8M | $51.0M | ||
| Q3 24 | $2.6M | $41.9M | ||
| Q2 24 | $-16.1M | $59.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | -30.2% | — | ||
| Q3 25 | -2.4% | — | ||
| Q2 25 | -2.1% | — | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | -1.1% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | -5.7% | — |
| Q1 26 | — | 27.6% | ||
| Q4 25 | -35.0% | 37.8% | ||
| Q3 25 | -1.9% | 23.0% | ||
| Q2 25 | -2.4% | 24.1% | ||
| Q1 25 | -0.2% | 44.5% | ||
| Q4 24 | -1.2% | 25.6% | ||
| Q3 24 | 0.8% | 21.9% | ||
| Q2 24 | -4.7% | 31.5% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $-2.56 | — | ||
| Q3 25 | $-0.15 | — | ||
| Q2 25 | $-0.20 | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $-0.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $8.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $3.6B |
| Total Assets | $449.0M | $7.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $8.9M | ||
| Q4 25 | $108.7M | $14.9M | ||
| Q3 25 | $99.1M | $17.3M | ||
| Q2 25 | $81.2M | $15.4M | ||
| Q1 25 | $80.7M | $9.3M | ||
| Q4 24 | $81.6M | $36.3M | ||
| Q3 24 | $64.0M | $70.0M | ||
| Q2 24 | $69.6M | $33.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.8B |
| Q1 26 | — | $3.6B | ||
| Q4 25 | $322.8M | $3.6B | ||
| Q3 25 | $408.1M | $3.4B | ||
| Q2 25 | $412.2M | $3.4B | ||
| Q1 25 | $418.2M | $3.5B | ||
| Q4 24 | $419.0M | $3.5B | ||
| Q3 24 | $424.7M | $3.3B | ||
| Q2 24 | $433.3M | $3.3B |
| Q1 26 | — | $7.2B | ||
| Q4 25 | $449.0M | $7.2B | ||
| Q3 25 | $538.2M | $6.9B | ||
| Q2 25 | $553.8M | $6.8B | ||
| Q1 25 | $576.2M | $6.8B | ||
| Q4 24 | $589.3M | $6.8B | ||
| Q3 24 | $597.4M | $6.6B | ||
| Q2 24 | $602.9M | $6.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.91× | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.88× | ||
| Q1 25 | — | 0.87× | ||
| Q4 24 | — | 0.88× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.84× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | — |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | 3.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | $104.5M | ||
| Q3 25 | $20.1M | $143.5M | ||
| Q2 25 | $4.2M | $111.9M | ||
| Q1 25 | $5.7M | $103.5M | ||
| Q4 24 | $24.2M | $104.9M | ||
| Q3 24 | $7.5M | $128.0M | ||
| Q2 24 | $82.4M | $122.2M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $43.8M | ||
| Q3 25 | $17.9M | $95.5M | ||
| Q2 25 | $2.3M | $62.3M | ||
| Q1 25 | $3.8M | $57.2M | ||
| Q4 24 | $21.7M | $37.6M | ||
| Q3 24 | $6.3M | $86.7M | ||
| Q2 24 | $79.6M | $105.0M |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 19.8% | ||
| Q3 25 | 7.2% | 45.2% | ||
| Q2 25 | 0.8% | 30.0% | ||
| Q1 25 | 1.3% | 27.8% | ||
| Q4 24 | 7.0% | 18.8% | ||
| Q3 24 | 2.0% | 45.5% | ||
| Q2 24 | 23.4% | 55.3% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 0.9% | 27.4% | ||
| Q3 25 | 0.9% | 22.7% | ||
| Q2 25 | 0.7% | 23.9% | ||
| Q1 25 | 0.6% | 22.5% | ||
| Q4 24 | 0.8% | 33.8% | ||
| Q3 24 | 0.4% | 21.6% | ||
| Q2 24 | 0.8% | 9.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.25× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 2.24× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 2.06× | ||
| Q3 24 | 2.92× | 3.06× | ||
| Q2 24 | — | 2.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
STAG
Segment breakdown not available.